CIK 0001357459 · Non-accelerated filer<br>Smaller reporting company
PALISADE BIO, INC.
Sign in to watch- Ticker
- PALI
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 522007292
- Phone
- (858) 704-4900
- Business address
- 7750 EL CAMINO REAL, SUITE 5200, CARLSBAD, CA, 92009
- Former names
- PALISADE BIO, INC., Seneca Biopharma, Inc., Neuralstem, Inc.
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Chief Financial Officer bought 19,481.24 shares at $0.14 ($2,799)
- 4 Open-market buy Chief Financial Officer bought 7,350 shares at $0.16 ($1,176)
- 4 Open-market buy Chief Executive Officer bought 40,000 shares at $0.25 ($10,000)
- 4 Open-market buy Chief Financial Officer bought 100,000 shares at $0.25 ($25,000)
- 4 Other acquisition Chief Financial Officer acquired 12,545 shares (other)
- 4 Open-market buy Chief Medical Officer bought 15,000 shares at $1.14 ($17,093)
- 4 Open-market buy Chief Executive Officer bought 10,000 shares at $1.18 ($11,800)
- 4 Open-market buy Chief Financial Officer bought 7,500 shares at $1.09 ($8,174)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 6 of 18 · 343 filings